GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

BioSyent RX.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

17.90

+1.13%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$43.1m

FY2016FY2025

Net income

C$9.0m

FY2016FY2025

Free cash flow

C$8.6m

FY2016FY2025

Shareholders' equity

C$41.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$43.1mC$35.0mC$31.6mC$27.9mC$28.6mC$22.3mC$21.4mC$21.5mC$20.8mC$17.9m
Gross profitC$33.0mC$27.9mC$25.1mC$22.9mC$22.6mC$17.4mC$16.6mC$16.6mC$16.0mC$14.1m
Research and developmentC$341,049C$171,373C$83,271C$218,499C$276,542C$241,558C$90,114C$107,457C$79,877C$63,841
Operating incomeC$11.3mC$9.1mC$7.5mC$7.0mC$8.2mC$5.0mC$5.4mC$6.8mC$6.9mC$5.8m
Net incomeC$9.0mC$7.3mC$6.5mC$5.5mC$6.3mC$3.8mC$4.4mC$5.7mC$5.2mC$4.3m
Diluted earnings per share0.800.630.550.450.500.290.320.400.360.30

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$49.4mC$41.4mC$41.5mC$40.5mC$37.2mC$33.6mC$31.0mC$31.2mC$25.1mC$19.2m
Cash and short-term investments——C$26.2mC$28.7mC$28.2mC$25.6mC$22.0mC$24.4mC$19.3mC$13.7m
Total liabilitiesC$8.0mC$6.4mC$6.8mC$7.1mC$5.6mC$6.8mC$5.2mC$3.6mC$2.9mC$2.5m
Debt—C$1.0mC$1.2mC$1.4mC$1.6mC$1.7mC$1.9m———
Shareholders' equityC$41.5mC$35.0mC$34.8mC$33.4mC$31.6mC$26.8mC$25.8mC$27.6mC$22.2mC$16.7m
Shares outstanding11m12m12m12m13m13m14m14m15m15m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsC$9.0mC$8.7mC$5.8mC$4.9mC$4.7mC$6.9mC$4.8mC$6.3mC$6.5mC$4.4m
Capital spending−C$389,808−C$4.7m−C$2.7m−C$519,317−C$93,181−C$174,298−C$734,131−C$504,025−C$640,475−C$405,464
Free cash flowC$8.6mC$4.0mC$3.2mC$4.4mC$4.6mC$6.7mC$4.0mC$5.8mC$5.9mC$4.0m
Dividends paid−C$2.3m−C$2.1m−C$1.9m−C$483,958−C$10,322−C$7,415−C$4,724———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$19.9mC$13.9mC$9.7mC$12.2mC$10.2mC$11.0mC$8.8mC$9.6m
Gross profitC$14.0mC$10.2mC$7.4mC$9.3mC$7.9mC$8.3mC$7.2mC$7.5m
Operating incomeC$4.1mC$3.4mC$2.4mC$3.4mC$2.6mC$2.9mC$2.4mC$2.7m
Net incomeC$2.8mC$2.3mC$2.0mC$2.7mC$2.0mC$2.3mC$1.6mC$2.3m
Diluted earnings per share0.250.210.180.240.180.210.140.20
Cash from operationsC$2.0mC$2.0mC$3.0mC$2.0mC$3.0m—C$2.0mC$6.0m
Capital spending———————−C$4.0m
Free cash flow———————C$2.0m
Total assetsC$60.5mC$62.5mC$49.4mC$47.8mC$43.5mC$42.8mC$41.4mC$45.5m
Shareholders' equityC$45.8mC$45.0mC$41.5mC$39.9mC$37.6mC$36.0mC$35.0mC$37.3m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.5%14.0%10.8%
Operating income17.5%17.6%8.4%
Net income18.2%18.9%9.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin77.9%79.1%79.0%78.5%
Operating margin26.1%25.4%25.5%27.3%
Net margin20.9%20.5%20.3%21.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings15.917.516.815.516.726.918.920.326.826.9
Price to sales3.33.63.43.03.74.63.95.46.76.5

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 27 Feb 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.0550.200.180.160.04

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.